Synaptic vesicle protein 2A (SV2A)

Assets acting on this target.

Class
SV2A ligand / Anticonvulsant
Pathway
Synaptic vesicle neurotransmitter release

By indication

Related mechanisms

Synaptic vesicle protein 2A (SV2A) drugs compared

2 drugs, stage by indication
2 drugs acting on Synaptic vesicle protein 2A (SV2A): developer, modality, furthest stage and stage in each indication. Furthest stage first.
DrugDeveloperModalityFurthest stageStage by indication
Levetiracetam (Keppra XR)Keppra XRUCBsmall moleculeApprovedApproved in Epilepsy; Approved in Focal Onset Seizures
Levetiracetam (Keppra)KeppraUCBsmall moleculeApprovedApproved in Epilepsy; Approved in Focal Onset Seizures; Approved in Primary Generalized Tonic-Clonic Seizures

← all mechanisms